TWD 65.1
(-0.61%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 162.91 Million TWD | -42.08% |
2022 | 281.25 Million TWD | -7.66% |
2021 | 304.57 Million TWD | 1.05% |
2020 | 301.4 Million TWD | 81.26% |
2019 | 166.28 Million TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 12.63 Million TWD | 0.0% |
2024 Q1 | 12.63 Million TWD | -7.81% |
2023 Q3 | 13.7 Million TWD | -78.18% |
2023 FY | 162.91 Million TWD | -42.08% |
2023 Q2 | 62.81 Million TWD | 0.0% |
2023 Q1 | 62.81 Million TWD | -7.79% |
2023 Q4 | 13.7 Million TWD | 0.0% |
2022 FY | 281.25 Million TWD | -7.66% |
2022 Q4 | 68.11 Million TWD | 0.0% |
2022 Q3 | 68.11 Million TWD | 0.0% |
2021 FY | 304.57 Million TWD | 1.05% |
2020 FY | 301.4 Million TWD | 81.26% |
2019 FY | 166.28 Million TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Allied Biotech Corporation | 97.41 Million TWD | -67.238% |
GeneFerm Biotechnology Co., Ltd. | 124.62 Million TWD | -30.724% |
Easywell Biomedicals, Inc. | -144.81 Million TWD | 212.493% |
TTY Biopharm Company Limited | 1.12 Billion TWD | 85.564% |
Synmosa Biopharma Corporation | 594.83 Million TWD | 72.612% |
Orient EuroPharma Co., Ltd. | 143.94 Million TWD | -13.177% |
Center Laboratories, Inc. | -995.42 Million TWD | 116.366% |
Tien Liang BioTech Co., Ltd. | 17.73 Million TWD | -818.734% |
Orient Pharma Co., Ltd. | 22.28 Million TWD | -630.931% |
InnoPharmax Inc. | -70.83 Million TWD | 329.998% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 79.7 Million TWD | -104.404% |
Excelsior Biopharma Inc. | -91.01 Million TWD | 279.0% |
Foresee Pharmaceuticals Co., Ltd. | -1.03 Billion TWD | 115.72% |
Handa Pharmaceuticals, Inc. | 726.88 Million TWD | 77.588% |
UniPharma Co., Ltd. | -21.81 Million TWD | 846.848% |
Anxo Pharmaceutical Co., Ltd. | 21.86 Million TWD | -645.208% |
Alar Pharmaceuticals Inc. | 382.61 Million TWD | 57.422% |
Winston Medical Supply Co., Ltd. | 158.75 Million TWD | -2.617% |
Mercury Biopharmaceutical Corporation | -43.81 Million TWD | 471.805% |
Bioray Biotech Co., Ltd | -11.55 Million TWD | 1509.378% |
TSH Biopharm Corporation Limited | 61.98 Million TWD | -162.805% |